ArticleCancers2022

Conventional Therapies Do Not Prolong the Prognosis of Hepatocellular Carcinoma Patients with Extrahepatic Metastases under Receiving of Tyrosine Kinase Inhibitors.

Hiroshi Maeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.